Some authors consider aCLA of the IgM class, especially when present in low titers, to be nonpathogenic, unlike the findings of IgG or IgA class aCLA, which are persistently found at higher titers in patients with thromboembolic diseases. This evidence concerns the gene CD40LG and Thromboembolism.